IRIS Accounts Production v25.3.0.601 SC098839 Board of Directors 1.4.24 31.3.25 31.3.25 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWhSC0988392024-03-31SC0988392025-03-31SC0988392024-04-012025-03-31SC0988392023-03-31SC0988392023-04-012024-03-31SC0988392024-03-31SC098839ns15:Scotland2024-04-012025-03-31SC098839ns14:PoundSterling2024-04-012025-03-31SC098839ns10:Director12024-04-012025-03-31SC098839ns10:PrivateLimitedCompanyLtd2024-04-012025-03-31SC098839ns10:SmallEntities2024-04-012025-03-31SC098839ns10:AuditExempt-NoAccountantsReport2024-04-012025-03-31SC098839ns10:SmallCompaniesRegimeForDirectorsReport2024-04-012025-03-31SC098839ns10:SmallCompaniesRegimeForAccounts2024-04-012025-03-31SC098839ns10:FullAccounts2024-04-012025-03-31SC098839ns10:Director22024-04-012025-03-31SC098839ns10:CompanySecretary12024-04-012025-03-31SC098839ns10:RegisteredOffice2024-04-012025-03-31SC098839ns5:CurrentFinancialInstruments2025-03-31SC098839ns5:CurrentFinancialInstruments2024-03-31SC098839ns5:Non-currentFinancialInstruments2025-03-31SC098839ns5:Non-currentFinancialInstruments2024-03-31SC098839ns5:ShareCapital2025-03-31SC098839ns5:ShareCapital2024-03-31SC098839ns5:RetainedEarningsAccumulatedLosses2025-03-31SC098839ns5:RetainedEarningsAccumulatedLosses2024-03-31SC098839ns5:OwnedOrFreeholdAssetsns5:LandBuildings2024-04-012025-03-31SC098839ns5:PlantMachinery2024-04-012025-03-31SC098839ns5:FurnitureFittings2024-04-012025-03-31SC098839ns5:MotorVehicles2024-04-012025-03-31SC098839ns5:LandBuildings2024-03-31SC098839ns5:PlantMachinery2024-03-31SC098839ns5:FurnitureFittings2024-03-31SC098839ns5:MotorVehicles2024-03-31SC098839ns5:LandBuildings2024-04-012025-03-31SC098839ns5:LandBuildings2025-03-31SC098839ns5:PlantMachinery2025-03-31SC098839ns5:FurnitureFittings2025-03-31SC098839ns5:MotorVehicles2025-03-31SC098839ns5:LandBuildings2024-03-31SC098839ns5:PlantMachinery2024-03-31SC098839ns5:FurnitureFittings2024-03-31SC098839ns5:MotorVehicles2024-03-31SC098839ns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-31SC098839ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-31SC098839ns5:Secured2025-03-31SC098839ns5:Secured2024-03-31
REGISTERED NUMBER: SC098839 (Scotland)
















Unaudited Financial Statements for the Year Ended 31 March 2025

for

Theraplay Limited

Theraplay Limited (Registered number: SC098839)






Contents of the Financial Statements
for the Year Ended 31 March 2025




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Theraplay Limited

Company Information
for the Year Ended 31 March 2025







DIRECTORS: I A Macdonald
G R Macdonald





SECRETARY: G R Macdonald





REGISTERED OFFICE: Middleton House
22 Hawbank Road
East Kilbride
Glasgow
G74 5HA





REGISTERED NUMBER: SC098839 (Scotland)





ACCOUNTANTS: McLay, McAlister & McGibbon LLP
Chartered Accountants
145 St Vincent Street
Glasgow
G2 5JF

Theraplay Limited (Registered number: SC098839)

Balance Sheet
31 March 2025

31.3.25 31.3.24
Notes £    £   
FIXED ASSETS
Tangible assets 4 340,348 353,579

CURRENT ASSETS
Stocks 131,907 154,668
Debtors 5 331,550 275,813
Cash at bank and in hand 176,829 148,891
640,286 579,372
CREDITORS
Amounts falling due within one year 6 (216,894 ) (177,934 )
NET CURRENT ASSETS 423,392 401,438
TOTAL ASSETS LESS CURRENT
LIABILITIES

763,740

755,017

CREDITORS
Amounts falling due after more than one year 7 (55,806 ) (78,679 )

PROVISIONS FOR LIABILITIES (3,224 ) (4,672 )
NET ASSETS 704,710 671,666

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 704,610 671,566
SHAREHOLDERS' FUNDS 704,710 671,666

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Theraplay Limited (Registered number: SC098839)

Balance Sheet - continued
31 March 2025


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Comprehensive Income has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 21 December 2025 and were signed on its behalf by:





G R Macdonald - Director


Theraplay Limited (Registered number: SC098839)

Notes to the Financial Statements
for the Year Ended 31 March 2025

1. STATUTORY INFORMATION

Theraplay Limited is a private company, limited by shares , registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover represents net invoiced sales of goods excluding value added tax. The turnover and profit before taxation are attributable to the principal activity of the company.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life.
Freehold property - 2% on cost
Plant and machinery - 15% on cost
Fixtures and fittings - 20% on cost
Motor vehicles - 25% on reducing balance

The company's policy is to review the remaining useful lives and residual value of all tangible fixed assets on an on-going basis and to adjust the depreciation charge to reflect the remaining useful economic life and residual value.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Financial instruments
Debtors
Trade debtors and other debtors are recognised at the settlement amount due with appropriate allowances for any irrecoverable amounts when there is objective evidence the asset is impaired.

Cash and cash equivalents
Cash and cash equivalent in the balance sheet comprise cash in hand and bank overdrafts.

Creditors
Trade creditors and other creditors are recognised where the company has a present obligation resulting from a past event and are recognised at the settlement amount due after allowing for any trade discounts due.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


Theraplay Limited (Registered number: SC098839)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2025

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Grants
Grants are credited to other income. Grants toward capital expenditure are released to the profit and loss account over the expected useful life of the assets.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 13 (2024 - 13 ) .

4. TANGIBLE FIXED ASSETS
Fixtures
Freehold Plant and and Motor
property machinery fittings vehicles Totals
£    £    £    £    £   
COST
At 1 April 2024 372,100 86,340 22,508 32,551 513,499
Additions - 2,198 - - 2,198
At 31 March 2025 372,100 88,538 22,508 32,551 515,697
DEPRECIATION
At 1 April 2024 37,210 75,461 21,228 26,021 159,920
Charge for year 7,442 5,075 1,280 1,632 15,429
At 31 March 2025 44,652 80,536 22,508 27,653 175,349
NET BOOK VALUE
At 31 March 2025 327,448 8,002 - 4,898 340,348
At 31 March 2024 334,890 10,879 1,280 6,530 353,579

Property purchased in 2019 is included at cost.

The directors consider this valuation to be appropriate as at 31 March 2025.

Theraplay Limited (Registered number: SC098839)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2025

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.25 31.3.24
£    £   
Trade debtors 329,690 263,549
Other debtors 1,860 12,264
331,550 275,813

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.25 31.3.24
£    £   
Bank loans and overdrafts 21,250 20,718
Trade creditors 49,047 47,259
Taxation and social security 40,443 22,080
Other creditors 106,154 87,877
216,894 177,934

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
31.3.25 31.3.24
£    £   
Bank loans 51,173 72,690
Other creditors 4,633 5,989
55,806 78,679

8. SECURED DEBTS

The following secured debts are included within creditors:

31.3.25 31.3.24
£    £   
Bank loans 72,423 93,408

Bank loans are secured over the assets of the company.